Beth Israel Deaconess Medical Center;Dana-Farber Cancer Institute, Inc.
发明人:
David Avigan,Jacalyn Rosenblatt,Donald Kufe
申请号：
US16348564
公开号：
US20200000896A1
申请日:
2017.11.14
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides compositions and methods for treating cancer, wherein the composition comprises: a. a population a cells comprising a dendritic cell/tumor cell fusion or a dendritic cell/extracellular vesicle fusion； and b. an indoleamine-2,3-dioxygenase (IDO) inhibitor and/or a hypomethylating agent (HMA).
